CRP and coinfection: Suggested as a biomarker to rule out bacterial complications/co-infections in patients with COVID-19 at the onset of the pandemic, C-reactive protein later proved to have low diagnostic value, being non-specific for bacterial infection and elevated in many hospitalized patients with COVID-19 [28,29].